bioAffinity Technologies annual revenue
2022
2023
2024
2025
bioAffinity Technologies Revenue Growth & History (BIAF)
bioAffinity Technologies reported $6.2M in revenue for fiscal 2025, a decrease of 34.18% from the previous fiscal year.
View full bioAffinity Technologies company overviewbioAffinity Technologies annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.2M | −$3.2M | −34.18% |
| 2024 | 2024-12-31 | $9.4M | $6.8M | +269.68% |
| 2023 | 2023-12-31 | $2.5M | $2.5M | +52627.44% |
| 2022 | 2022-12-31 | $4,803 | — | — |
bioAffinity Technologies quarterly revenue
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.5M | $241,096 | +18.99% |
| Q1 2026 | 2026-03-31 | $1.4M | −$502,070 | −27.09% |
| Q4 2025 | 2025-12-31 | $1.6M | −$614,780 | −27.85% |
| Q3 2025 | 2025-09-30 | $1.4M | −$904,320 | −38.48% |
| Q2 2025 | 2025-06-30 | $1.3M | −$1.1M | −47.05% |
| Q1 2025 | 2025-03-31 | $1.9M | −$552,794 | −22.97% |
| Q4 2024 | 2024-12-31 | $2.2M | −$5,763 | −0.26% |
| Q3 2024 | 2024-09-30 | $2.4M | $2.1M | +687.44% |
| Q2 2024 | 2024-06-30 | $2.4M | $2.4M | +12047.39% |
| Q1 2024 | 2024-03-31 | $2.4M | $2.4M | +261180.24% |
| Q4 2023 | 2023-12-31 | $2.2M | — | — |
| Q3 2023 | 2023-09-30 | $298,484 | $297,334 | +25855.13% |
| Q2 2023 | 2023-06-30 | $19,738 | $18,432 | +1411.33% |
| Q1 2023 | 2023-03-31 | $921 | — | — |
| Q3 2022 | 2022-09-30 | $1,150 | — | — |
| Q2 2022 | 2022-06-30 | $1,306 | — | — |
bioAffinity Technologies revenue growth trends
bioAffinity Technologies's latest reported quarter, Q2 2026, generated $1.5M in revenue, an increase of 18.99% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review bioAffinity Technologies source filings ↗